Marie Holmqvist is a medical doctor at Karolinska University Hospital and docent (often translated as associate professor) at the Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet.
Together with her team, Dr Holmqvist is researching comorbidities and prognosis of patients with rheumatic diseases, with a particular focus on systemic inflammatory diseases such as idiopathic inflammatory myopathies, and systemic sclerosis. Their aim is to decrease their patients burden of disease and identify strategies that will prolong their lives.
Their projects are mainly focused around cancer and the connection between cancer and autoimmunity/inflammation. Dr Holmqvist recently initiated a collaboration between Karolinska Institutet, McGill University, and Oslo University, with a project where they aim to identify molecular pathways that could be of interest in cancer in inflammatory diseases. They are also using machine learning methods to identify predictors of cancer in their patients.
The research conducted by Team Holmqvist is supported by The Swedish Research Council, The Marianne and Marcus Wallenberg Foundation, The Swedish Society of Medicine, Reumatikerfonden, The Professor Nanna Svartz Foundation, Gustaf V:s 80 year Fund, and by Region Stockholm (ALF project).
Marie Holmqvist currently holds a clinical research appointment funded by the Swedish Research Council.